MEDIOCON INC offers Caralluma fimbriata Standardized Extract, a specialty botanical ingredient derived from the succulent plant Caralluma fimbriata Wall.
Caralluma fimbriata belongs to the family Apocynaceae and is native to India, Sri Lanka and Myanmar. It is a succulent subshrub traditionally used as a food and botanical ingredient. Kew's Plants of the World Online currently recognizes Caralluma fimbriata as the accepted species name.
Caralluma is characterized by pregnane-type steroidal glycosides, together with other phytochemical classes including flavonoids, sterols, triterpenoids and related compounds. A recent review of the genus identified pregnane steroid glycosides as principal metabolites across Caralluma species.
Caralluma fimbriata Standardized Extract is a concentrated botanical ingredient designed to provide a more consistent phytochemical profile than unstandardized plant powder.
The characteristics of the finished extract depend on:
Commercial Caralluma extracts have been characterized using pregnane glycosides as important marker compounds. One published analysis of a commercial C. fimbriata extract reported approximately 12% pregnane glycosides, while other commercial specifications describe different standardization levels.
Scientific Name: Caralluma fimbriata Wall.
Common Name: Caralluma
Family: Apocynaceae
Genus: Caralluma
Plant Type: Succulent subshrub
Native Range: India, Sri Lanka and Myanmar
Caralluma adscendens var. fimbriata (Wall.) Gravely & Mayur. is recognized as a synonym of Caralluma fimbriata.
Caralluma species contain several classes of naturally occurring phytochemicals.
Pregnane-type steroidal glycosides are among the characteristic constituents associated with Caralluma.
The plant contains steroidal compounds and related glycosides that contribute to its characteristic phytochemical profile.
Flavonoid glycosides and flavones have also been reported within the genus.
Reported phytochemical classes include:
The exact standardization should be specified according to the actual commercial product.
Possible specifications include:
A published commercial-product analysis reported approximately 12% pregnane glycosides, while another commercial specification lists 30% pregnane glycosides. These demonstrate that standardization varies between products and should not be combined into one generic specification.
Concentrated botanical extract processed into a dry powder.
Powdered extract suitable for incorporation into capsules, tablets, sachets and powder blends.
Available according to supplier specification, such as a defined drug-to-extract ratio.
Exact extraction ratio should be confirmed from the current supplier specification.
Caralluma fimbriata Standardized Extract may be used in:
Caralluma has historically been investigated and marketed in appetite-management contexts, but product pages should avoid disease-treatment or guaranteed weight-loss claims unless specifically permitted by the applicable regulatory framework.
MEDIOCON INC can support commercial sourcing requirements with available technical and quality documentation, subject to supplier availability.
Typical documentation may include:
| Parameter | Specification |
|---|---|
| Appearance | Light yellow to brown botanical extract powder |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Caralluma fimbriata Standardized Extract Manufacturer & Supplier in India | MEDIOCON INC (CAS 532-32-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Caralluma fimbriata Standardized Extract Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance